Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Clinical trial NCT06929039 · COMPLETED

Trial details

NCT number: NCT06929039
Sponsor: Kashiv BioSciences, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA

Start date: 2024-07-04
Primary completion: 2024-10-16
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.